Baillie Gifford & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,395
Closed -$27.1K 344
2023
Q1
$27.1K Buy
1,395
+165
+13% +$2.88K ﹤0.01% 319
2022
Q4
$19.7K Hold
1,230
﹤0.01% 346
2022
Q3
$19K Hold
1,230
﹤0.01% 340
2022
Q2
$26K Buy
1,230
+30
+3% +$618 ﹤0.01% 318
2022
Q1
$27K Hold
1,200
﹤0.01% 329
2021
Q4
$22K Hold
1,200
﹤0.01% 368
2021
Q3
$25K Buy
+1,200
New +$22.3K ﹤0.01% 336
2013
Q4
Sell
-15,912
Closed -$93K 211
2013
Q3
$93K Hold
15,912
﹤0.01% 202
2013
Q2
$72K Buy
+15,912
New +$75.4K ﹤0.01% 182

Other funds holding EXEL

Baillie Gifford & Co's EXEL Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Exelixis (EXEL) in Q2 2023, closing a stake of 1,395 shares — an estimated $27.1K sold.

Baillie Gifford & Co first reported a position in EXEL in Q2 2013 and held it in 9 quarters. The position peaked at $93K in Q3 2013. 378 funds tracked by Wall St. Rank hold EXEL as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Exelixis position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 1,395 Exelixis shares in Q2 2023, an estimated $27.1K.
  • Baillie Gifford & Co first reported a position in Exelixis in Q2 2013 and held it in 9 quarters.
  • Baillie Gifford & Co's Exelixis position peaked at $93K in Q3 2013.
  • 378 funds tracked by Wall St. Rank held Exelixis as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.